PF00610335

PF00610335 · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF00610335, covering 2011-01-13 to 2011-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers [Phase 1]